NVUS - Novus Therapeutics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate-0.29-0.29-1.4-1.47
Low Estimate-0.29-0.29-1.4-1.47
High Estimate-0.29-0.29-1.4-1.47
Year Ago EPS-1.53-1.53-2.3-1.4
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20163/30/20176/29/201712/30/2017
EPS Est.-3.06-2.7-2.7-0.38
EPS Actual-1.53-1.53-1.32-0.05
Difference1.531.171.380.33
Surprise %50.00%43.30%51.10%86.80%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.29-0.29-1.4-1.47
7 Days Ago-0.39-0.46-1.92-1.03
30 Days Ago-0.39-0.46-1.92-1.03
60 Days Ago00-0.39-1.03
90 Days Ago00-0.39-1.03
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 Days111N/A
Up Last 30 Days111N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNVUSIndustrySectorS&P 500
Current Qtr.81.00%N/AN/A0.42
Next Qtr.81.00%N/AN/A0.39
Current Year39.10%N/AN/A0.20
Next Year-5.00%N/AN/A0.10
Next 5 Years (per annum)-65.60%N/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A